Carmustine Supplier-Buyer Network — Trade Flow Analysis

Name: Carmustine Supplier-Buyer Trade Network Dataset — 50+ Indian Exporters, 18+ Importers, 54+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Carmustine supplier network, Carmustine buyers, pharmaceutical export India, Carmustine trade data

TransData Nexus

Carmustine

India Pharmaceutical Trade Intelligence

$22.5M50 Suppliers54 CountriesHS 30049049

ExportsIndia → UNITED KINGDOM58.1%India → CANADA12.6%

ImportsAUSTRALIA → India$6.1K TAIWAN → India$153

#1 Supplier: EMCURE PHARMACEUTICALS

Who Supplies Carmustine? Top Manufacturers & Buyers 2026 — EMCURE PHARMACEUTICALS LIMITED Leads | TransData Nexus | TransData Nexus

1EMCURE PHARMACEUTICALS LIMITED

EMCURE PHARMACEUTICALS LIMITED is the first-largest Carmustine exporter from India, with a market share of 54.2% and a total export value of $12.2M across 81 shipments. Their average shipment value of $150.6K is above the market average of $66.2K, suggesting premium or bulk contract pricing.

EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. TILLOMED LABORATORIES LIMITED is the dominant customer, accounting for 79.2% of this supplier's tracked business. Top customers include:

• TILLOMED LABORATORIES LIMITED — $9.7M across 64 shipments (79.2% of this supplier's total exports)

• TILLOMED MALTA LTD — $1.8M across 12 shipments (15.1% of this supplier's total exports)

• HIND WING CO.LTD. — $257.2K across 2 shipments (2.1% of this supplier's total exports)

• JSC VILNIAUS TRANZITAS — $237.6K across 2 shipments (1.9% of this supplier's total exports)

• TILLOMED ITALIA SRL . — $208.8K across 1 shipments (1.7% of this supplier's total exports)

Key Insight: EMCURE PHARMACEUTICALS LIMITED's per-shipment value of $150.6K is 128% above the market average of $66.2K, consistent with large-order contracts or value-added formulations.

2MSN LABORATORIES PRIVATE LIMITED

MSN LABORATORIES PRIVATE LIMITED is the second-largest Carmustine exporter from India, with a market share of 10.6% and a total export value of $2.4M across 17 shipments. Their average shipment value of $139.6K is above the market average of $66.2K, suggesting premium or bulk contract pricing.

MSN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. STERIMAX INC is the dominant customer, accounting for 78.9% of this supplier's tracked business. Top customers include:

• STERIMAX INC — $1.9M across 13 shipments (78.9% of this supplier's total exports)

• TO THE ORDER OF — $357.5K across 3 shipments (15.1% of this supplier's total exports)

• PHARMADOX HEALTHCARE — $64.0K across 0 shipments (2.7% of this supplier's total exports)

• PHARMADOX HEALTHCARE — $57.7K across 0 shipments (2.4% of this supplier's total exports)

• NOVADOZ PHARMACEUTIC — $20.4K across 0 shipments (0.9% of this supplier's total exports)

Key Insight: MSN LABORATORIES PRIVATE LIMITED's per-shipment value of $139.6K is 111% above the market average of $66.2K, consistent with large-order contracts or value-added formulations.

3INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the third-largest Carmustine exporter from India, with a market share of 4.9% and a total export value of $1.1M across 44 shipments. Their average shipment value of $24.9K is below the market average of $66.2K, reflecting a high-volume, competitive pricing strategy.

INTAS PHARMACEUTICALS LIMITED serves 1 named buyer in our database. AVET PHARMACEUTICALS INC. is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• AVET PHARMACEUTICALS INC. — $1.1M across 44 shipments (100.0% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (44 shipments) at a per-shipment value of $24.9K, indicating a broad distribution network with many smaller, regular orders.

4SP ACCURE LABS PRIVATE LIMITED

SP ACCURE LABS PRIVATE LIMITED is the fourth-largest Carmustine exporter from India, with a market share of 1.3% and a total export value of $289.0K across 23 shipments. Their average shipment value of $12.6K is below the market average of $66.2K, reflecting a high-volume, competitive pricing strategy.

SP ACCURE LABS PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• DRAGON PHARMACEUTICAL CO LIMITED — $98.9K across 8 shipments (34.2% of this supplier's total exports)

• DRAGON PHARMACEUTICAL CO LIMITED — $48.2K across 4 shipments (16.7% of this supplier's total exports)

• LABORATORIOS KAMPAR — $23.4K across 2 shipments (8.1% of this supplier's total exports)

• LABORATORIOS KAMPAR — $19.5K across 2 shipments (6.8% of this supplier's total exports)

Key Insight: SP ACCURE LABS PRIVATE LIMITED operates with high shipment frequency (23 shipments) at a per-shipment value of $12.6K, indicating a broad distribution network with many smaller, regular orders.

5EMCURE PHARMACEUTICALS LTD

EMCURE PHARMACEUTICALS LTD is the fifth-largest Carmustine exporter from India, with a market share of 0.8% and a total export value of $175.6K across 3 shipments. Their average shipment value of $58.5K is below the market average of $66.2K, reflecting a high-volume, competitive pricing strategy.

EMCURE PHARMACEUTICALS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• H O PHARM CO LIMITED — $49.9K across 1 shipments (28.4% of this supplier's total exports)

• NEXT PHRMA SOURCING — $43.9K across 1 shipments (25.0% of this supplier's total exports)

• ASPIGEN INC — $43.5K across 1 shipments (24.8% of this supplier's total exports)

• AYUSH PHARMA S A DE — $20.7K across 0 shipments (11.8% of this supplier's total exports)

• ASPIGEN INC — $17.6K across 0 shipments (10.0% of this supplier's total exports)

Key Insight: EMCURE PHARMACEUTICALS LTD operates with high shipment frequency (3 shipments) at a per-shipment value of $58.5K, indicating a broad distribution network with many smaller, regular orders.

6THERDOSE PHARMA PRIVATE LIMITED

THERDOSE PHARMA PRIVATE LIMITED is the fifth-largest Carmustine exporter from India, with a market share of 0.1% and a total export value of $30.3K across 22 shipments. Their average shipment value of $1.4K is below the market average of $66.2K, reflecting a high-volume, competitive pricing strategy.

THERDOSE PHARMA PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• BROCACEF NL:HUB BRO — $10.3K across 7 shipments (33.8% of this supplier's total exports)

• BROCACEF NL : DUTCH — $6.5K across 5 shipments (21.4% of this supplier's total exports)

• BROCACEF NL : DUTCH — $5.1K across 4 shipments (16.8% of this supplier's total exports)

• TO THE ORDER — $4.9K across 4 shipments (16.1% of this supplier's total exports)

• BROCACEF NL HUB — $3.6K across 3 shipments (12.0% of this supplier's total exports)

Key Insight: THERDOSE PHARMA PRIVATE LIMITED operates with high shipment frequency (22 shipments) at a per-shipment value of $1.4K, indicating a broad distribution network with many smaller, regular orders.

1United Kingdom

United Kingdom ranks as the first-largest destination for Carmustine imports from India, with a total trade value of $13.1M across 18 shipments — representing a 58.1% share of all Carmustine exports. The average shipment value of $726.4K is above the global average of $66.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Carmustine importers in United Kingdom: TILLOMED LABORATORIES LTD is the largest buyer, accounting for 97.9% ($12.8M) of this market's total imports.

• TILLOMED LABORATORIES LTD — $12.8M (97.9% of United Kingdom's total)

• TILLOMED LABORATORIES LIMITED — $267.4K (2.0% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $726.4K (998% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Carmustine imports from India.

Primary Market

Secondary Market

2Canada

Canada ranks as the second-largest destination for Carmustine imports from India, with a total trade value of $2.8M across 7 shipments — representing a 12.6% share of all Carmustine exports. The average shipment value of $403.9K is above the global average of $66.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Carmustine importers in Canada: STERIMAX INC is the largest buyer, accounting for 66.3% ($1.9M) of this market's total imports.

• STERIMAX INC — $1.9M (66.3% of Canada's total)

Key Insight: Canada's per-shipment average of $403.9K (511% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Carmustine imports from India.

Primary Market

Secondary Market

3Malta

Malta ranks as the third-largest destination for Carmustine imports from India, with a total trade value of $2.0M across 23 shipments — representing a 8.7% share of all Carmustine exports. The average shipment value of $85.2K is above the global average of $66.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Carmustine importers in Malta: TILLOMED MALTA LTD is the largest buyer, accounting for 93.7% ($1.8M) of this market's total imports.

• TILLOMED MALTA LTD — $1.8M (93.7% of Malta's total)

Key Insight: Malta's per-shipment average of $85.2K (29% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Malta is a key market for Carmustine imports from India.

Primary Market

Secondary Market

4United States

United States ranks as the fourth-largest destination for Carmustine imports from India, with a total trade value of $1.8M across 5 shipments — representing a 7.9% share of all Carmustine exports. The average shipment value of $357.3K is above the global average of $66.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Carmustine importers in United States: AVET PHARMACEUTICALS INC. is the largest buyer, accounting for 61.5% ($1.1M) of this market's total imports.

• AVET PHARMACEUTICALS INC. — $1.1M (61.5% of United States's total)

• EVERSANA LIFE SCIENCES SERVICES,LLC — $461.6K (25.8% of United States's total)

Key Insight: United States's per-shipment average of $357.3K (440% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Carmustine imports from India.

Primary Market

Secondary Market

5Lithuania

Lithuania ranks as the fifth-largest destination for Carmustine imports from India, with a total trade value of $462.6K across 3 shipments — representing a 2.1% share of all Carmustine exports. The average shipment value of $154.2K is above the global average of $66.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Carmustine importers in Lithuania: JSC VILNIAUS TRANZITAS is the largest buyer, accounting for 100.0% ($462.6K) of this market's total imports.

• JSC VILNIAUS TRANZITAS — $462.6K (100.0% of Lithuania's total)

Key Insight: Lithuania's per-shipment average of $154.2K (133% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Lithuania is a key market for Carmustine imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Carmustine.
2.Flow Mapping: 50 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 340 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 54 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

340 Verified Shipments

50 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Carmustine

Carmustine

Who Supplies Carmustine? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Carmustine? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Carmustine Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1EMCURE PHARMACEUTICALS LIMITED

2MSN LABORATORIES PRIVATE LIMITED

3INTAS PHARMACEUTICALS LIMITED

4SP ACCURE LABS PRIVATE LIMITED

5EMCURE PHARMACEUTICALS LTD

6THERDOSE PHARMA PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Carmustine Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Carmustine Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United Kingdom

2Canada

3Malta

4United States

5Lithuania

People Also Ask — Carmustine Supplier & Trade Network

Carmustine Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology